Pioglitazone is Back

762 views
681 views

Published on

The Union Ministry of Health and Family Welfare on Wednesday endorsed the recommendation of the Drugs Technical Advisory Board (DTAB) to revoke the ban on pioglitazone — an oral anti-diabetic drug which was banned on June 18. The drug will now be sold with a box warning (that the drug carries a significant risk of serious or even life-threatening adverse effects) and will also carry an inset. Doctors will also be told that pioglitazone should not be prescribed as the first line of treatment.

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
762
On SlideShare
0
From Embeds
0
Number of Embeds
2
Actions
Shares
0
Downloads
7
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

×